PURPLE BIOTECH LTD. (PPBT) Free cash flow 2016–2025
PURPLE BIOTECH LTD. (PPBT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$5.7MFY2025 · since FY2016: -$6.3M → -$5.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.7M | — |
| FY2023 | -$19.9M | -18.9% |
| FY2022 | -$16.8M | -3327.6% |
| FY2021 | -$489,000 | -131.6% |
| FY2020 | $1.5M | +178.3% |
| FY2019 | -$2.0M | +76.7% |
| FY2018 | -$8.5M | +1.7% |
| FY2017 | -$8.6M | -37.8% |
| FY2016 | -$6.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PPBT financial trends
PPBT RevenuePPBT Net incomePPBT Net marginPPBT Gross profitPPBT Gross marginPPBT Operating incomePPBT Operating marginPPBT Operating cash flowPPBT Capital expendituresPPBT Return on equityPPBT Stock buybacksPPBT Dividends paidPPBT Total assetsPPBT Total liabilitiesPPBT Shareholders’ equityPPBT overview →